Neuropilin‐1 expression by tumor cells promotes tumor angiogenesis and progression
Open Access
- 6 October 2000
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 14 (15), 2532-2539
- https://doi.org/10.1096/fj.00-0250com
Abstract
Neuropilin-1 (NRP1) is a VEGF165 and semaphorin receptor expressed by vascular endothelial cells (EC) and tumor cells. The function of NRP1 in tumor cells is unknown. NRP1 was overexpressed in Dunnin...Keywords
Funding Information
- National Institutes of Health (CA37392, CA45548)
This publication has 47 references indexed in Scilit:
- The Hallmarks of CancerCell, 2000
- Clinical applications of angiogenic growth factors and their inhibitorsNature Medicine, 1999
- Molecular angiogenesisChemistry & Biology, 1999
- Vascular endothelial growth factor (VEGF) and its receptorsThe FASEB Journal, 1999
- Vascular Permeability Factor/Vascular Endothelial Growth Factor and the Significance of Microvascular Hyperpermeability in AngiogenesisPublished by Springer Nature ,1999
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisCell, 1996
- Angiogenesis in cancer, vascular, rheumatoid and other diseaseNature Medicine, 1995
- Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivoNature, 1993
- Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesisNature, 1992
- Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivoNature, 1992